Catalyst Wire Dossier Catalyst Wire Dossier

Onglyza (saxagliptin)

saxagliptin · AstraZeneca
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Onglyza (saxagliptin), covering 2011-05-11 to 2017-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis [Phase 3]

See pricing